Ex-As­traZeneca ex­ec Kris­ten Buck hops aboard Icon as CMO; Im­muno­core taps Bri­an Di­Do­na­to as CFO

→ Promi­nent CRO play­er Icon is bol­ster­ing its lead­er­ship, with Kris­ten Buck tak­ing the reins as CMO.

For slight­ly more than a year and a half, Buck was the SVP & chief of clin­i­cal de­vel­op­ment at Op­tum, part of the Unit­ed­Health con­glom­er­ate. When she got there, she had al­ready held a post at the FDA in the gas­troin­testi­nal and hema­tol­ogy di­vi­sion, tasked with post-mar­ket­ing safe­ty for over 40 drugs. She had al­so spent 6 years as an ex­ec at As­traZeneca in clin­i­cal de­vel­op­ment and in its in­no­v­a­tive med­i­cines group.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER